跳至主要内容
临床试验/JPRN-UMIN000044289
JPRN-UMIN000044289暂停1 期

The prospective study of focal high-dose rate brachytherapy for low or intermediate risk primary clinically localized prostate cancer - The prospective study of focal high-dose rate brachytherapy for low or intermediate risk primary clinically localized prostate cancer

Kawasaki Medical School Hospita, Department of Urology0 个研究点目标入组 20 人开始时间: 2021年6月1日最近更新:
适应症

试验速览

阶段
1 期
状态
暂停
发起方
入组人数
20

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
20years-old 至 ot applicable(—)
性别
Male

入选标准

  • 未提供

排除标准

  • 1.Prostate cancer region and size that unsuitable brachytherapy 2.multiple cancer region diagnosed by prostate biopsy 3.Medical history for radiation therapy of the pelvis 4.Unfit for regularly MRI examination for follow-up 5.Administration of glucocorticoid or 5-arufa reductase 6.Actively double cancer

研究者

发起方
Kawasaki Medical School Hospita, Department of Urology

相似试验